Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mary A. Slivka"'
Autor:
Herbert B. Newton, Gregory A. Christoforidis, Eric C. Bourekas, Melissa A. Baujan, Wayne Slone, Donald W. Chakeres, Mary A. Slivka, Carol Volpi
Publikováno v:
Journal of Neuro-Oncology. 61:35-44
Metastatic brain tumors (MBT) are the most frequent complication of systemic cancer and often respond poorly to treatment. Median survival is only 16-24 weeks after conventional radiation therapy. Regional intra-arterial (IA) administration of chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fd8f2f483900dabda7b2cb9e2f1925b7
https://doi.org/10.1023/a:1021218207015
https://doi.org/10.1023/a:1021218207015
Autor:
Mary A. Slivka, Gregory A. Christoforidis, Carol Stevens, Melissa A. Baujan, Donald W. Chakeres, Eric C. Bourekas, Herbert B. Newton
Publikováno v:
Journal of Neuro-Oncology. 56:79-86
Recurrent and progressive non-GBM gliomas are a diverse group of brain tumors that often respond poorly to adjuvant chemotherapy treatment. Regional intra-arterial (IA) administration of chemotherapy may result in increased tumor uptake of drug, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6ab15cf176ee53f0cd72fbf2c012012d
https://doi.org/10.1023/a:1014498225405
https://doi.org/10.1023/a:1014498225405
Publikováno v:
Journal of Neuro-Oncology. 49:165-170
Meningiomas represent 18-20% of all intracranial tumors and have a 10-year recurrence rate of 20-50%, despite aggressive surgery and irradiation. In addition, many tumors are not amenable to surgery due to their deep location or proximity to delicate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb4c143d5c6d9fd09b9e07c82cc247de
https://doi.org/10.1023/a:1026770624783
https://doi.org/10.1023/a:1026770624783
Autor:
Herbert B, Newton, Mary A, Slivka, Carol, Volpi, Eric C, Bourekas, Gregory A, Christoforidis, Melissa A, Baujan, Wayne, Slone, Donald W, Chakeres
Publikováno v:
Journal of neuro-oncology. 61(1)
Metastatic brain tumors (MBT) are the most frequent complication of systemic cancer and often respond poorly to treatment. Median survival is only 16-24 weeks after conventional radiation therapy. Regional intra-arterial (IA) administration of chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5d0ffce781685d0b915be0dbb497ba7d
https://pubmed.ncbi.nlm.nih.gov/12587794
https://pubmed.ncbi.nlm.nih.gov/12587794
Autor:
Herbert B, Newton, Mary Ann, Slivka, Carol L, Stevens, Eric C, Bourekas, Gregory A, Christoforidis, Melissa A, Baujan, Donald W, Chakeres
Publikováno v:
Journal of neuro-oncology. 56(1)
Recurrent and progressive non-GBM gliomas are a diverse group of brain tumors that often respond poorly to adjuvant chemotherapy treatment. Regional intra-arterial (IA) administration of chemotherapy may result in increased tumor uptake of drug, with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::05332c6a71e1ce96d80886d3cabd6d9e
https://pubmed.ncbi.nlm.nih.gov/11949830
https://pubmed.ncbi.nlm.nih.gov/11949830